Anaptys to Present at Guggenheim's 6th Annual Biotechnology Conference

SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer, will present at Guggenheim’s 6th Annual Biotechnology Conference. Investor Conference Details Event - Guggenheim’s 6th Annual Biotechnology ConferenceFormat – Fireside chatDate and Time – Wednesday, Feb. 7, 2024 at 9:30am ET / 6:30am PT A live webcast of the fires ...